Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Abbott Laboratories ABT
Healthcare - Medical - Devices - NYSE - US
Watchlist
$ 115.9
0.756 %
$ 201 B
Market Cap
35.23
P/E
Price Target
Average
16.52%
Revenue Forecast
Estimate
8.36%
EBIT
Estimate
11.63%
Net Income
Estimate
20.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Abbott Laboratories
Wall Street analysts predict an average 1-year price target for
ABT
of
$135
, with forecasts ranging from a low of
$50
to a high of
$345
.
ABT Lowest Price Target
Wall Street Target
50 USD
-56.86%
ABT Average Price Target
Wall Street Target
135 USD
16.52%
ABT Highest Price Target
Wall Street Target
345 USD
197.67%
REVENUE FORECAST
Revenue Forecast Chart
ABT
EBIT FORECAST
EBIT Forecast Chart
ABT
NET INCOME FORECAST
Net Income Chart
ABT
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan